相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。How to fix a broken protein: restoring function to mutant human cystathionine β-synthase
Warren D. Kruger
HUMAN GENETICS (2022)
Efficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION study
Paolo Ventura et al.
LIVER INTERNATIONAL (2022)
Givosiran in acute intermittent porphyria: A personalized medicine approach
Antoine Poli et al.
MOLECULAR GENETICS AND METABOLISM (2022)
Derangement of hepatic polyamine, folate, and methionine cycle metabolism in cystathionine beta-synthase-deficient homocystinuria in the presence and absence of treatment: Possible implications for pathogenesis
Kenneth N. Maclean et al.
MOLECULAR GENETICS AND METABOLISM (2021)
Cardiovascular manifestations of intermediate and major hyperhomocysteinemia due to vitamin B12 and folate deficiency and/or inherited disorders of one-carbon metabolism: a 3.5-year retrospective cross-sectional study of consecutive patients
Julien Levy et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2021)
Hyperhomocysteinemia in patients with cardiovascular manifestations: to treat or not to treat
Amanda J. MacFarlane
AMERICAN JOURNAL OF CLINICAL NUTRITION (2021)
Profiling of Serum Metabolites of Acute Intermittent Porphyria and Asymptomatic HMBS Mutation Carriers
Chia-Ni Lin et al.
CELLS (2021)
Dysregulation of homocysteine homeostasis in acute intermittent porphyria patients receiving heme arginate or givosiran
Jordi To-Figueras et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
Renal Function Decline With Small Interfering RNA Silencing ALAS1 for Acute Intermittent Porphyria
Helene Lazareth et al.
KIDNEY INTERNATIONAL REPORTS (2021)
Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?
Petro E. Petrides et al.
ANNALS OF HEMATOLOGY (2021)
A Drug-Drug Interaction Study Evaluating the Effect of Givosiran, a Small Interfering Ribonucleic Acid, on Cytochrome P450 Activity in the Liver
Daphne Vassiliou et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)
Hyperhomocysteinemia in patients with acute porphyrias: a possible effect of ALAS1 modulation by siRNAm therapy and its control by vitamin supplementation
Andrea Ricci et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)
Acute intermittent porphyria, givosiran, and homocysteine
Antonio Fontanellas et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2021)
Homocysteine elevation in givosiran treatment: Suggested ALAS1 siRNA effect on cystathionine beta-synthase
Daphne Vassiliou et al.
JOURNAL OF INTERNAL MEDICINE (2021)
EXPLORE: A Prospective, Multinational, Natural History Study of Patients with Acute Hepatic Porphyria with Recurrent Attacks
Laurent Gouya et al.
HEPATOLOGY (2020)
Elevated homocysteine and differential risks of the renal function decline in hypertensive patients
Chunlei Liu et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2020)
Association Between Homocysteine and Vascular Calcification Incidence, Prevalence, and Progression in the MESA Cohort
Amy B. Karger et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad?
Paolo Ventura et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Nutrients and Porphyria: An Intriguing Crosstalk
Elena Di Pierro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cystathionine-beta-synthase: Molecular Regulation and Pharmacological Inhibition
Karim Zuhra et al.
BIOMOLECULES (2020)
Folic Acid Supplementation in Patients with Elevated Homocysteine Levels
Alan D. Kaye et al.
ADVANCES IN THERAPY (2020)
Proteomic exploration of cystathionine β-synthase deficiency: implications for the clinic
Hieronim Jakubowski
EXPERT REVIEW OF PROTEOMICS (2020)
Update on Safety Profiles of Vitamins B1, B6, and B12: A Narrative Review
Carlos-Alberto Calderon-Ospina et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Hyperhomocysteinemia: Clinical Insights
Fuad Al Mutairi
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2020)
Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)
Herbert L. Bonkovsky et al.
MOLECULAR GENETICS AND METABOLISM (2019)
Phase 1 Trial of an RNA Interference Therapy for Acute Intermittent Porphyria
Eliane Sardh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Hyperhomocysteinemia and Risk of First Venous Thrombosis: The Influence of (Unmeasured) Confounding Factors
Monica Ospina-Romero et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2018)
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics
Aaron D. Springer et al.
NUCLEIC ACID THERAPEUTICS (2018)
Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency
Martina Huemer et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency
Andrew A. M. Morris et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2017)
Clinical pattern, mutations and in vitro residual activity in 33 patients with severe 5, 10 methylenetetrahydrofolate reductase (MTHFR) deficiency
Martina Huemer et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Mutation Update and Review of Severe Methylenetetrahydrofolate Reductase Deficiency
D. Sean Froese et al.
HUMAN MUTATION (2016)
The Molecular and Cellular Effect of Homocysteine Metabolism Imbalance on Human Health
Henrieta Skovierova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification
Amy Chan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2015)
Severe Methylenetetrahydrofolate Reductase Deficiency Clinical Clues to a Potentially Treatable Cause of Adult-Onset Hereditary Spastic Paraplegia
Alexander Lossos et al.
JAMA NEUROLOGY (2014)
Assessing nutritional status of acute intermittent porphyria patients
Luis Garcia-Diz et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication Bias
Robert Clarke et al.
PLOS MEDICINE (2012)
Vitamin B6 and Oxalic Acid in Clinical Nephrology
Miroslav Mydlik et al.
JOURNAL OF RENAL NUTRITION (2010)
Preliminary report Hyperhomocysteinemia in patients with acute intermittent porphyria
Jordi To-Figueras et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Chronic Pancreatitis Is Associated With Hyperhomocysteinemia and Derangements in Transsulfuration and Transmethylation Pathways
Banavara Narasimhamurthy Girish et al.
PANCREAS (2010)
Dietary Supplement S-Adenosyl-L-Methionine (AdoMet) Effects on Plasma Homocysteine Levels in Healthy Human Subjects: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Michael A. Thompson et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2009)
Plasma pyridoxal 5′-phosphate in the US population:: the National Health and Nutrition Examination Survey, 2003-2004
Martha Savaria Morris et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Homocysteine lowering by B vitamins and the secondary prevention of deep vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
Martin den Heijer et al.
BLOOD (2007)
Toxicity of methionine in humans
Peter J. Garlick
JOURNAL OF NUTRITION (2006)
Recommendations for the diagnosis and treatment of the acute porphyrias
KE Anderson et al.
ANNALS OF INTERNAL MEDICINE (2005)
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
DS Wald et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis
R Clarke et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine β-synthase (CBS) deficiency
R Yaghmai et al.
AMERICAN JOURNAL OF MEDICAL GENETICS (2002)
Drugs affecting homocysteine metabolism - Impact on cardiovascular risk
C Desouza et al.
DRUGS (2002)
S-adenosylmethionine: a control switch that regulates liver function
JM Mato et al.
FASEB JOURNAL (2002)
Structure of human cystathionine β-synthase:: a unique pyridoxal 5′-phosphate-dependent heme protein
M Meier et al.
EMBO JOURNAL (2001)
Acute and chronic pancreatitis in patients with inborn errors of metabolism
P Simon et al.
PANCREATOLOGY (2001)
Acute pancreatitis in homocystinuria
RJ Makins et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2000)
分享论文
